About NovaMed Pharmaceuticals
NovaMed Pharmaceuticals is a company based in Shanghai (China) founded in 2005 was acquired by SciClone Pharmaceuticals in April 2011.. NovaMed Pharmaceuticals has raised $18.8 million across 2 funding rounds from investors including Atlas Venture, SciClone Pharmaceuticals and Eight Roads Ventures.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$18.8 M (USD)
in 2 rounds
-
Latest Funding Round
$13.8 M (USD), Series B
Jan 22, 2008
-
Investors
Atlas Venture
& 2 more
-
Employee Count
Employee Count
-
Acquired by
SciClone Pharmaceuticals
(Apr 19, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of NovaMed Pharmaceuticals
NovaMed Pharmaceuticals has successfully raised a total of $18.8M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $13.8 million completed in January 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $13.8M
-
First Round
First Round
(31 Jul 2007)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2008 | Amount | Series B - NovaMed Pharmaceuticals | Valuation |
investors |
|
| Jul, 2007 | Amount | Series A - NovaMed Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NovaMed Pharmaceuticals
NovaMed Pharmaceuticals has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Atlas Venture, SciClone Pharmaceuticals and Eight Roads Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life science and biotechnology sectors
|
Founded Year | Domain | Location | |
|
Venture capital investment and global platform support for startups.
|
Founded Year | Domain | Location | |
|
Specialty biopharma company that develops and commercializes specialist-oriented drugs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NovaMed Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NovaMed Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Novamed Pharmaceuticals Comparisons
Competitors of NovaMed Pharmaceuticals
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Novamed Pharmaceuticals
Frequently Asked Questions about NovaMed Pharmaceuticals
When was NovaMed Pharmaceuticals founded?
NovaMed Pharmaceuticals was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Where is NovaMed Pharmaceuticals located?
NovaMed Pharmaceuticals is headquartered in Shanghai, China.
Is NovaMed Pharmaceuticals a funded company?
NovaMed Pharmaceuticals is a funded company, having raised a total of $18.8M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Jul 31, 2007.
What does NovaMed Pharmaceuticals do?
NovaMed Pharmaceuticals was founded in 2005 and is headquartered in Shanghai, China. The company operates in the pharmaceutical sector, where therapeutics are developed for oncology, cardiovascular disease, central nervous system disorders, urology, and infections. Key products include the broad-spectrum anti-convulsant Depakine, the anti-hypertension ACE inhibitor Tritace, the hypnotic anti-insomnia drug Stilnox, and the interventional cardiology product Aggrastat. Operations focus on research and development in these therapeutic areas.
Who are NovaMed Pharmaceuticals's investors?
NovaMed Pharmaceuticals has 3 investors. Key investors include Atlas Venture, SciClone Pharmaceuticals, and Eight Roads Ventures.